Lascufloxacin

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameLascufloxacin
Drug Alias Namelascufloxacino拉库沙星lascufloxacinumlascufloxacinelascufloxacin hydrochloride +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsOtorhinolaryngologic DiseasesPneumoniaRespiratory Tract Infections
Global Approved IndicationsOtorhinolaryngologic DiseasesPneumoniaRespiratory Tract Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/09/20
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Holdings Inc
Inactive CompaniesN/A
Active IndicationsOtorhinolaryngologic DiseasesPneumoniaRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01MA
Related LinksDrugBankKEGG